These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 15541895)
1. Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia. Muthian S; Rademacher DJ; Roelke CT; Gross GJ; Hillard CJ Neuroscience; 2004; 129(3):743-50. PubMed ID: 15541895 [TBL] [Abstract][Full Text] [Related]
2. CB1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus. Béquet F; Uzabiaga F; Desbazeille M; Ludwiczak P; Maftouh M; Picard C; Scatton B; Le Fur G Eur J Neurosci; 2007 Dec; 26(12):3458-64. PubMed ID: 18052990 [TBL] [Abstract][Full Text] [Related]
3. 2-Arachidonylglycerol acting on CB1 cannabinoid receptors mediates delayed cardioprotection induced by nitric oxide in rat isolated hearts. Wagner JA; Abesser M; Harvey-White J; Ertl G J Cardiovasc Pharmacol; 2006 May; 47(5):650-5. PubMed ID: 16775503 [TBL] [Abstract][Full Text] [Related]
5. Hypotensive effect of anandamide through the activation of CB1 and VR1 spinal receptors in urethane-anesthetized rats. del Carmen García M; Adler-Graschinsky E; Celuch SM Naunyn Schmiedebergs Arch Pharmacol; 2003 Oct; 368(4):270-6. PubMed ID: 14504685 [TBL] [Abstract][Full Text] [Related]
6. Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats. Nucci C; Gasperi V; Tartaglione R; Cerulli A; Terrinoni A; Bari M; De Simone C; Agrò AF; Morrone LA; Corasaniti MT; Bagetta G; Maccarrone M Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2997-3004. PubMed ID: 17591864 [TBL] [Abstract][Full Text] [Related]
7. Effects of cannabinoid receptor agonist WIN 55,212-2 on blood-brain barrier disruption in focal cerebral ischemia in rats. Chi OZ; Barsoum S; Grayson J; Hunter C; Liu X; Weiss HR Pharmacology; 2012; 89(5-6):333-8. PubMed ID: 22678129 [TBL] [Abstract][Full Text] [Related]
8. CB1 receptor blockade reduces the anxiogenic-like response and ameliorates the neurochemical imbalances associated with alcohol withdrawal in rats. Rubio M; Fernández-Ruiz J; de Miguel R; Maestro B; Michael Walker J; Ramos JA Neuropharmacology; 2008 May; 54(6):976-88. PubMed ID: 18371990 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the neuroprotective effect of the cannabinoid agonist WIN-55212 in an in vitro model of hypoxic-ischemic brain damage in newborn rats. Fernández-López D; Martínez-Orgado J; Nuñez E; Romero J; Lorenzo P; Moro MA; Lizasoain I Pediatr Res; 2006 Aug; 60(2):169-73. PubMed ID: 16864698 [TBL] [Abstract][Full Text] [Related]
10. O-2050 facilitates noradrenaline release and increases the CB1 receptor inverse agonistic effect of rimonabant in the guinea pig hippocampus. Jergas B; Schulte K; Bindila L; Lutz B; Schlicker E Naunyn Schmiedebergs Arch Pharmacol; 2014 Jul; 387(7):621-8. PubMed ID: 24853577 [TBL] [Abstract][Full Text] [Related]
11. CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations. Citraro R; Russo E; Ngomba RT; Nicoletti F; Scicchitano F; Whalley BJ; Calignano A; De Sarro G Epilepsy Res; 2013 Sep; 106(1-2):74-82. PubMed ID: 23860329 [TBL] [Abstract][Full Text] [Related]
13. Pretreatment with electroacupuncture induces rapid tolerance to focal cerebral ischemia through regulation of endocannabinoid system. Wang Q; Peng Y; Chen S; Gou X; Hu B; Du J; Lu Y; Xiong L Stroke; 2009 Jun; 40(6):2157-64. PubMed ID: 19372445 [TBL] [Abstract][Full Text] [Related]
14. The hypothermic response to bacterial lipopolysaccharide critically depends on brain CB1, but not CB2 or TRPV1, receptors. Steiner AA; Molchanova AY; Dogan MD; Patel S; Pétervári E; Balaskó M; Wanner SP; Eales J; Oliveira DL; Gavva NR; Almeida MC; Székely M; Romanovsky AA J Physiol; 2011 May; 589(Pt 9):2415-31. PubMed ID: 21486787 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats. Zaniewska M; McCreary AC; Przegaliński E; Filip M Eur J Pharmacol; 2006 Jul; 540(1-3):96-106. PubMed ID: 16730696 [TBL] [Abstract][Full Text] [Related]
16. A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. Gómez R; Navarro M; Ferrer B; Trigo JM; Bilbao A; Del Arco I; Cippitelli A; Nava F; Piomelli D; Rodríguez de Fonseca F J Neurosci; 2002 Nov; 22(21):9612-7. PubMed ID: 12417686 [TBL] [Abstract][Full Text] [Related]
17. 2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons. Llorente-Berzal A; Terzian AL; di Marzo V; Micale V; Viveros MP; Wotjak CT Psychopharmacology (Berl); 2015 Aug; 232(15):2811-25. PubMed ID: 25814137 [TBL] [Abstract][Full Text] [Related]
20. Effects of SR141716 and WIN 55,212-2 on tolerance to ethanol in rats using the acute and rapid procedures. Lemos JI; Takahashi RN; Morato GS Psychopharmacology (Berl); 2007 Oct; 194(2):139-49. PubMed ID: 17546513 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]